Drospirenone - Contraception

You are here : Home > Formulary Search > Drospirenone - Contraception

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines BNF SPC

Restrictions / Comments :

Important

2nd line after desogestrel. Caution - may have different drug interactions to other progestogen-only pills.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Drospirenone

Indication :

Contraception

Group Name :

Keywords :

POP, progestogen-only contraceptives, oral contraceptives, contraceptive pills

Brand Names Include :

Slynd

Important Information :

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Contraception

Supporting Documents :

Other Indications

Below are listed other indications that Drospirenone is used to treat.

Menopausal disorders

Other Drugs

Below are listed other drugs that are used to treat Contraception.

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agreed a Green traffic light status (with restrictions) for drospirenone (Slynd®) for contraception

Restricted use as a second line treatment option, after desogestrel, in women requiring progestogen-only contraception who do not have risk factors for potassium elevation (renal impairment, hypoadrenalism, concomitant use of potassium-elevating medicines)

Caution: May have different drug interactions to other progestogen only pills (POP)